14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CARA ranks #11529 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Cara Therapeutics Stock Forecast NASDAQ:CARA

$11.95 (2.58%)

Volume: 307k

Closed: Jan 14, 2022

Hollow Logo Score: -2.344

Cara Therapeutics Stock Forecast

$11.95 (2.58%)

Volume: 307k

Closed: Jan 14, 2022

Score Hollow Logo -2.344

Cara Therapeutics Stock Price (Quote) NASDAQ:CARA

$11.95 ( 2.58% ) Friday, 14th Jan 2022

Range Low Price High Price Comment
30 days $11.50 $12.97 Friday, 14th Jan 2022 CARA stock ended at $11.95. This is 2.58% more than the trading day before Thursday, 13th Jan 2022. During the day the stock fluctuated 3.54% from a day low at $11.58 to a day high of $11.99.
90 days $11.50 $18.93
52 weeks $11.22 $29.65

Historical Cara Therapeutics prices

Date Open High Low Close Volume
2022-01-14 $11.70 $11.99 $11.58 $11.95 307 393
2022-01-13 $11.89 $12.01 $11.61 $11.65 271 915
2022-01-12 $12.33 $12.36 $11.91 $11.93 245 507
2022-01-11 $11.99 $12.37 $11.99 $12.29 348 251
2022-01-10 $11.76 $12.16 $11.53 $12.13 498 117
2022-01-07 $11.73 $11.98 $11.62 $11.76 431 892
2022-01-06 $11.70 $11.93 $11.50 $11.66 301 800
2022-01-05 $12.49 $12.66 $11.65 $11.67 515 862
2022-01-04 $12.70 $12.97 $12.34 $12.48 356 767
2022-01-03 $12.30 $12.77 $12.16 $12.65 385 031
2021-12-31 $12.34 $12.58 $12.16 $12.18 328 501
2021-12-30 $12.21 $12.75 $12.04 $12.34 433 099
2021-12-29 $12.32 $12.40 $12.10 $12.21 349 539
2021-12-28 $12.51 $12.65 $12.23 $12.25 319 074
2021-12-27 $12.68 $12.76 $12.46 $12.57 294 558
2021-12-23 $12.38 $12.73 $12.18 $12.66 396 252
2021-12-22 $12.29 $12.48 $12.14 $12.27 312 919
2021-12-21 $12.29 $12.51 $12.18 $12.29 417 571
2021-12-20 $12.38 $12.40 $11.95 $12.21 630 868
2021-12-17 $12.05 $12.67 $11.85 $12.45 1 560 397
2021-12-16 $12.48 $12.52 $12.05 $12.18 598 021
2021-12-15 $11.97 $12.50 $11.62 $12.48 668 911
2021-12-14 $12.02 $12.17 $11.77 $11.99 425 935
2021-12-13 $12.27 $12.35 $11.93 $12.18 515 253
2021-12-10 $12.52 $12.66 $12.07 $12.10 438 065
2021-12-09 $12.67 $12.95 $12.35 $12.37 430 168
2021-12-08 $12.82 $13.03 $12.59 $12.80 317 219
2021-12-07 $12.22 $12.95 $12.22 $12.74 477 963
2021-12-06 $12.31 $12.50 $12.04 $12.14 425 602
2021-12-03 $12.90 $13.02 $12.22 $12.31 499 775
2021-12-02 $12.61 $12.91 $12.39 $12.89 704 158
2021-12-01 $13.30 $13.32 $12.61 $12.61 688 108
2021-11-30 $13.00 $13.40 $12.70 $13.18 919 732
2021-11-29 $12.95 $13.23 $12.54 $12.58 507 214
2021-11-26 $13.25 $13.30 $12.49 $12.80 510 563
2021-11-24 $13.26 $13.46 $13.06 $13.34 521 643
2021-11-23 $13.58 $13.92 $13.24 $13.44 940 034
2021-11-22 $14.16 $14.45 $13.50 $13.63 728 116
2021-11-19 $14.40 $14.72 $14.15 $14.18 636 416
2021-11-18 $14.86 $14.99 $14.12 $14.44 726 385
2021-11-17 $15.20 $15.48 $14.78 $14.84 721 755
2021-11-16 $15.50 $15.64 $15.11 $15.32 567 031
2021-11-15 $16.13 $16.28 $15.43 $15.64 537 665
2021-11-12 $16.30 $16.58 $15.93 $16.25 460 870
2021-11-11 $16.93 $17.39 $16.16 $16.17 550 381
2021-11-10 $17.77 $18.60 $16.54 $16.56 906 893
2021-11-09 $17.23 $18.93 $17.23 $18.14 1 269 486
2021-11-08 $17.81 $17.99 $17.16 $17.23 543 243
2021-11-05 $17.63 $18.28 $17.30 $17.89 711 599
2021-11-04 $17.20 $17.87 $16.86 $17.65 594 999

About Cara Therapeutics

Cara Therapeutics Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system. Its lead product candidate includes I.V. CR845, which is in Phase III clinical trials for the treatment acute postop... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT